Clonidine gel - Curatek Pharmaceuticals

Drug Profile

Clonidine gel - Curatek Pharmaceuticals

Latest Information Update: 04 May 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Curatek Pharmaceuticals
  • Class Analgesics; Anti-inflammatories; Antiglaucomas; Antimigraines; Centrally-acting antihypertensives; Chlorobenzenes; Imidazolines; Small molecules
  • Mechanism of Action Alpha 2 adrenergic receptor agonists; Imidazoline I1 receptor agonists; Imidazoline receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Diabetic neuropathies; Postherpetic neuralgia

Most Recent Events

  • 04 May 2007 Discontinued - Phase-III for Diabetic neuropathies in USA (Topical)
  • 04 May 2007 Discontinued - Phase-III for Postherpetic neuralgia in USA (Topical)
  • 13 Mar 2000 Phase-III clinical trials for Diabetic neuropathies in USA (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top